Resthetics is a medical device company that has developed a system and process to capture waste gases such as anesthetics from hospital operating rooms. We can then manufacture this captured waste into a safe reusable generic form to be chemically identical to what it was before capturing. Our initial targets are fluorinated anesthetics such as Isoflurane, Sevoflurane, and Desflurane. Through a simple process of adsorption, Resthetics will serve as a cost effective solution to the $1.5 billion worth of these fluorinated anesthetics released from U.S. hospital operating rooms annually. The demand for fluorinated anesthetics is also increasing due to an aging population, increased life expectancy, and healthcare reform. Given that pharmaceutical prices are on the rise and a new found focus on global warming, we feel Resthetics is prime for entering the market right now. If you have any questions or would like more information please feel free to reach out to our CEO, Daniel Weisfeld, directly. Daniel Weisfeld 713-303-0466 daniel@resthetics.com